AstraZeneca's SERENA-4 trial misses main goal for Etcamah in first-line breast cancerSep 14Clinical readoutAstraZenecacamizestrant
FDA approves AstraZeneca's Etcamah for HR-positive breast cancerSep 8Regulatory decisionAstraZenecacamizestrant
FDA drug application records confirm Etcamah approval details, dosage formSep 4Regulatory decisionAstraZenecacamizestrant
AstraZeneca's Etcamah wins EU approval for 1st-line ER+ breast cancerJul 23Regulatory decisionAstraZenecacamizestrant
AstraZeneca registers Phase III bladder cancer trial; joins Natera-led breast cancer studyJul 23Weekly roundup, 5 itemsAstraZenecaAZD6489
Sign inSign in